Golden logo
    Create a WorkspaceQuery ToolSaved QueriesData RequestsListsPipelinesExploreFollowed Topics
    Upgrade to ProPricingAPI AccessHelp & Support
Log in
Sign up
NEW: You can now make knowledge queries using our new natural language prompt. Try it out now!
⟶
Rodeo Therapeutics

Rodeo Therapeutics

Rodeo Therapeutics is a preclinical-stage biotech company focused on first in class small molecule modulators of prostaglandin biology for enhancing tissue repair and regeneration.

OverviewStructured DataIssuesContributorsActivity
Contents

Rodeo Therapeutics is a biopharmaceutical company that develops small-molecule therapies, which are designed to enhance regeneration and repair of multiple tissues.

Rodeo Therapeutics was launched by two top researchers from the Case Western Reserve University School of Medicine and a third person who is a scientific partner. The company focuses on small molecule modulators of prostaglandin biology for promoting tissue repair and regeneration.

The company was founded based on the discoveries that were published in the peer-reviewed journal Science by three scientific founders: Sanford Markowitz, the Ingalls Professor of Cancer Genetics and Distinguished University Professor at Case Western Reserve; Stanton Gerson, interim dean of the Case Western Reserve School of Medicine and director of the Case Comprehensive Cancer Center; and Joseph Ready, a biochemistry professor at the University of Texas Southwestern.

Rodeo Therapeutics has been sold to Amgen Inc., a publicly traded international biopharmaceutical company.

Timeline

July 26, 2017
Rodeo Therapeutics raises a $5,900,000 series A round.
July 2017
Rodeo Therapeutics raises a $5,900,000 series A round from ARCH Venture Partners, AbbVie Biotech Ventures, Eli Lilly and Company, Johnson & Johnson Innovation – JJDC, WRF Capital and WuXi AppTec.

Funding Rounds

Open in Query Tool

Patents

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

References

rodeotherapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Therapeutics
Therapeutics
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Location
Seattle
Seattle
Thousand Oaks, California
Thousand Oaks, California
Founder
‌
Joseph Ready
‌
Sanford Markowitz
‌
Stanton Gerson
Legal Name
Rodeo Therapeutics Corp
Full Address
One Amgen Center Drive Thousand Oaks, CA 91320-1799
Investors
Eli Lilly and Company
Eli Lilly and Company
WuXi AppTec
WuXi AppTec
ARCH Venture Partners
ARCH Venture Partners
WRF Capital
WRF Capital
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC
AbbVie Biotech Ventures
AbbVie Biotech Ventures
Founded Date
2017
Phone Number
+18054471000
Total Funding Amount (USD)
11,800,000
Latest Funding Round Date
July 26, 2017
Latest Funding Type
Series A round
Series A round
Wellfound ID
rodeo-therapeutics

Other attributes

Company Operating Status
Active
Country
United States
United States
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
OverviewKnowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseProtocol
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.